These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 33145950)

  • 1. HLA class II eplet mismatch load improves prediction of dnDSA development after living donor kidney transplantation.
    Tafulo S; Malheiro J; Santos S; Dias L; Almeida M; Martins S; Pedroso S; Mendes C; Lobato L; Castro-Henriques A
    Int J Immunogenet; 2021 Feb; 48(1):1-7. PubMed ID: 33145950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of HLA Eplet Mismatch on De Novo Donor Specific Antibody Formation After Kidney Transplantation.
    Yanyiam P; Kantachuvesiri S; Thammanichanond D
    Transplant Proc; 2024 Apr; 56(3):515-520. PubMed ID: 38368130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Donor-Recipient Matching Based on Predicted Indirectly Recognizable HLA Epitopes Independently Predicts the Incidence of De Novo Donor-Specific HLA Antibodies Following Renal Transplantation.
    Lachmann N; Niemann M; Reinke P; Budde K; Schmidt D; Halleck F; Pruß A; Schönemann C; Spierings E; Staeck O
    Am J Transplant; 2017 Dec; 17(12):3076-3086. PubMed ID: 28613392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Eplet mismatch scores and de novo donor-specific antibody development in simultaneous pancreas-kidney transplantation.
    Ladowski JM; Mullins H; Romine M; Kloda D; Young C; Hauptfeld-Dolejsek V; Houp J; Locke J
    Hum Immunol; 2021 Mar; 82(3):139-146. PubMed ID: 33390268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Class II Eplet Mismatch Modulates Tacrolimus Trough Levels Required to Prevent Donor-Specific Antibody Development.
    Wiebe C; Rush DN; Nevins TE; Birk PE; Blydt-Hansen T; Gibson IW; Goldberg A; Ho J; Karpinski M; Pochinco D; Sharma A; Storsley L; Matas AJ; Nickerson PW
    J Am Soc Nephrol; 2017 Nov; 28(11):3353-3362. PubMed ID: 28729289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The association between human leukocyte antigen eplet mismatches, de novo donor-specific antibodies, and the risk of acute rejection in pediatric kidney transplant recipients.
    Sharma A; Taverniti A; Graf N; Teixeira-Pinto A; Lewis JR; Lim WH; Alexander SI; Durkan A; Craig JC; Wong G
    Pediatr Nephrol; 2020 Jun; 35(6):1061-1068. PubMed ID: 32065279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Degree of HLA class II eplet mismatch load improves prediction of antibody-mediated rejection in living donor kidney transplantation.
    Tafulo S; Malheiro J; Santos S; Dias L; Almeida M; Martins S; Pedroso S; Mendes C; Lobato L; Castro-Henriques A
    Hum Immunol; 2019 Dec; 80(12):966-975. PubMed ID: 31604581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human leukocyte antigen epitope mismatch loads and the development of de novo donor-specific antibodies in cardiothoracic organ transplantation.
    Bedford A; Jervis S; Worthington J; Lowe M; Poulton K
    Int J Immunogenet; 2022 Feb; 49(1):30-38. PubMed ID: 34904369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Class II HLA epitope matching-A strategy to minimize de novo donor-specific antibody development and improve outcomes.
    Wiebe C; Pochinco D; Blydt-Hansen TD; Ho J; Birk PE; Karpinski M; Goldberg A; Storsley LJ; Gibson IW; Rush DN; Nickerson PW
    Am J Transplant; 2013 Dec; 13(12):3114-22. PubMed ID: 24164958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eplet Mismatch Load and
    Senev A; Coemans M; Lerut E; Van Sandt V; Kerkhofs J; Daniëls L; Driessche MV; Compernolle V; Sprangers B; Van Loon E; Callemeyn J; Claas F; Tambur AR; Verbeke G; Kuypers D; Emonds MP; Naesens M
    J Am Soc Nephrol; 2020 Sep; 31(9):2193-2204. PubMed ID: 32764139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Eplet mismatches associated with de novo donor-specific HLA antibody in pediatric kidney transplant recipients.
    Charnaya O; Jones J; Philogene MC; Chiang PY; Segev DL; Massie AB; Garonzik-Wang J
    Pediatr Nephrol; 2021 Dec; 36(12):3971-3979. PubMed ID: 34100108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is the level of HLA eplet mismatch a risk factor for graft loss among kidney transplant recipients who have already formed de novo donor specific antibody?
    Wen J; Basu A; Bentall A; Henderson N; Dukek B; Gandhi M; Schinstock C
    Hum Immunol; 2021 Apr; 82(4):240-246. PubMed ID: 33618904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mismatch epitope load predicts de novo-DSA-free survival in pediatric liver transplantation.
    Shin S; Lee M; Dente E; Yazigi N; Khan KM; Kaufman SS; Ahn J; Timofeeva OA; Ekong UD
    Pediatr Transplant; 2022 Jun; 26(4):e14251. PubMed ID: 35279919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Application of HLA molecular level mismatching in ethnically diverse kidney transplant recipients receiving a steroid-sparing immunosuppression protocol.
    Santos E; Spensley K; Gunby N; Worthington J; Roufosse C; Anand A; Willicombe M
    Am J Transplant; 2024 Jul; 24(7):1218-1232. PubMed ID: 38403189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined Analysis of HLA Class II Eplet Mismatch and Tacrolimus Levels for the Prediction of De Novo Donor Specific Antibody Development in Kidney Transplant Recipients.
    Lee H; Min JW; Kang H; Lee H; Eum SH; Park Y; Yang CW; Chung BH; Oh EJ
    Int J Mol Sci; 2022 Jul; 23(13):. PubMed ID: 35806362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Which is the best predictor of de novo donor-specific antibodies in a cohort of non-sensitized first kidney transplantation: Antigenic, allelic, epitope, or physiochemical HLA mismatches?
    Delion A; Girerd S; Duarte K; Girerd N; Schikowski J; Kessler M; Frimat L; Aarnink A
    Clin Transplant; 2019 Apr; 33(4):e13508. PubMed ID: 30821002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HLA-DQ mismatches stimulate de novo donor specific antibodies in heart transplant recipients.
    Zhang X; Kransdorf E; Levine R; Patel JK; Kobashigawa JA
    Hum Immunol; 2020 Jul; 81(7):330-336. PubMed ID: 32307126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Donor-Specific Antibodies in Pediatric Intestinal and Multivisceral Transplantation: The Role of Liver and Human Leukocyte Antigen Mismatching.
    Talayero P; Ramos Boluda E; Gómez Massa E; Castro Panete MJ; Prieto Bozano G; Hernández Oliveros F; López Santamaría M; Calvo Pulido J; Paz-Artal E; Mancebo E
    Liver Transpl; 2018 Dec; 24(12):1726-1735. PubMed ID: 30112820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of risk epitope mismatches associated with de novo donor-specific HLA antibody development in cardiothoracic transplantation.
    McCaughan JA; Battle RK; Singh SKS; Tikkanen JM; Moayedi Y; Ross HJ; Singer LG; Keshavjee S; Tinckam KJ
    Am J Transplant; 2018 Dec; 18(12):2924-2933. PubMed ID: 29847022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of T and B Cell Epitopes to Predict the Risk of
    Sakamoto S; Iwasaki K; Tomosugi T; Niemann M; Spierings E; Miwa Y; Horimi K; Takeda A; Goto N; Narumi S; Watarai Y; Kobayashi T
    Front Immunol; 2020; 11():2000. PubMed ID: 32973806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.